Agomab Therapeutics
AGMB
#7859
Rank
โ‚ฌ0.37 B
Marketcap
7,70ย โ‚ฌ
Share price
-22.07%
Change (1 day)
N/A
Change (1 year)

Agomab Therapeutics (AGMB) - Total assets

Total assets on the balance sheet as of June 2026 : โ‚ฌ0.29 Billion

According to Agomab Therapeutics 's latest financial reports the company's total assets are โ‚ฌ0.29 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Agomab Therapeutics - Total assets on balance sheet (from 2024 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ0.15 B-25.51%
2024-12-31โ‚ฌ0.20 B20.49%
2023-12-31โ‚ฌ0.17 B69.57%
2022-12-31โ‚ฌ0.10 B20.23%
2021-12-31โ‚ฌ83.99 M